hypoglycemia and glp-1 Frontiers Frontiers | Glucagon-like peptide-1 receptor

GLP-1s can make a significant dent in the obesity epidemic and reduce downstream costs of treating diabetes, chronic kidney disease, liver disease, musculoskeletal conditions, and more

Don't just pick the one you've heard more about

Connect with an expert clinician: A licensed clinician will review your survey results and, if clinically appropriate, provide a prescriptionall online

If myBMI decides treatment is not suitable, your request is rejected and you are not charged

Feb 2021;25(4):473-485

Sign In Sign Out My Account Subscribe BioWorld - Monday, July 27, 2026 See today's BioWorld Asia Home Apollo signs near-$1B deal for Sunshines FGF21/GLP-1 injection To read the full story, subscribe or sign in